Dowling & Yahnke’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $515K | Buy |
2,358
+18
| +0.8% | +$3.93K | 0.02% | 275 |
|
|
2022
Q2 | $491K | Hold |
2,340
| – | – | 0.02% | 275 |
|
|
2022
Q1 | $567K | Hold |
2,340
| – | – | 0.02% | 264 |
|
|
2021
Q4 | $610K | Hold |
2,340
| – | – | 0.03% | 257 |
|
|
2021
Q3 | $617K | Sell |
2,340
-127
| -5% | -$33.5K | 0.03% | 252 |
|
|
2021
Q2 | $608K | Hold |
2,467
| – | – | 0.03% | 246 |
|
|
2021
Q1 | $479K | Sell |
2,467
-400
| -14% | -$77.7K | 0.03% | 252 |
|
|
2020
Q4 | $609K | Buy |
2,867
+25
| +0.9% | +$5.31K | 0.04% | 233 |
|
|
2020
Q3 | $487K | Sell |
2,842
-50
| -2% | -$8.57K | 0.04% | 232 |
|
|
2020
Q2 | $555K | Sell |
2,892
-10
| -0.3% | -$1.92K | 0.05% | 219 |
|
|
2020
Q1 | $427K | Sell |
2,902
-50
| -2% | -$7.36K | 0.04% | 226 |
|
|
2019
Q4 | $457K | Sell |
2,952
-110
| -4% | -$17K | 0.04% | 240 |
|
|
2019
Q3 | $414K | Buy |
3,062
+222
| +8% | +$30K | 0.03% | 243 |
|
|
2019
Q2 | $347K | Sell |
2,840
-2
| -0.1% | -$244 | 0.03% | 254 |
|
|
2019
Q1 | $295K | Buy |
2,842
+332
| +13% | +$34.5K | 0.03% | 233 |
|
|
2018
Q4 | $281K | Hold |
2,510
| – | – | 0.03% | 223 |
|
|
2018
Q3 | $290K | Sell |
2,510
-50
| -2% | -$5.78K | 0.03% | 253 |
|
|
2018
Q2 | $265K | Buy |
2,560
+400
| +19% | +$41.4K | 0.02% | 255 |
|
|
2018
Q1 | $213K | Sell |
2,160
-300
| -12% | -$29.6K | 0.02% | 273 |
|
|
2017
Q4 | $208K | Buy |
+2,460
| New | +$208K | 0.02% | 284 |
|